These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 8809141)
21. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801 [TBL] [Abstract][Full Text] [Related]
22. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays. Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504 [TBL] [Abstract][Full Text] [Related]
23. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane. Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450 [TBL] [Abstract][Full Text] [Related]
24. A self T cell epitope induces autoantibody response: mechanism for production of antibodies to diverse glomerular basement membrane antigens. Wu J; Arends J; Borillo J; Zhou C; Merszei J; McMahon J; Lou YH J Immunol; 2004 Apr; 172(7):4567-74. PubMed ID: 15034074 [TBL] [Abstract][Full Text] [Related]
25. Analysis of T cell responses to the autoantigen in Goodpasture's disease. Derry CJ; Ross CN; Lombardi G; Mason PD; Rees AJ; Lechler RI; Pusey CD Clin Exp Immunol; 1995 May; 100(2):262-8. PubMed ID: 7743665 [TBL] [Abstract][Full Text] [Related]
26. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease. Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145 [TBL] [Abstract][Full Text] [Related]
27. Identification of the Goodpasture antigen, alpha 3(IV) NC1, and four other NC1 domains of type IV collagen, by amino-terminal sequence analysis of human glomerular basement membrane separated by two-dimensional electrophoresis. Derry CJ; Pickering M; Baker C; Pusey CD Exp Nephrol; 1994; 2(4):249-56. PubMed ID: 7520821 [TBL] [Abstract][Full Text] [Related]
28. Sera from patients with anti-GBM nephritis including goodpasture syndrome show heterogenous reactivity to recombinant NC1 domain of type IV collagen alpha chains. Dehan P; Weber M; Zhang X; Reeders ST; Foidart JM; Tryggvason K Nephrol Dial Transplant; 1996 Nov; 11(11):2215-22. PubMed ID: 8941581 [TBL] [Abstract][Full Text] [Related]
29. Characterization of a non-Goodpasture autoantibody to type IV collagen. Johansson C; Butkowski R; Swedenborg P; Alm P; Wieslander J Nephrol Dial Transplant; 1993; 8(11):1205-10. PubMed ID: 8302456 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the NC1 domain of collagen type IV in glomerular basement membranes (GBM) and of antibodies to GBM in a patient with anti-GBM nephritis. Thorner PS; Baumal R; Eddy A; Marrano P Clin Nephrol; 1989 Mar; 31(3):160-8. PubMed ID: 2706812 [TBL] [Abstract][Full Text] [Related]
31. Induction of anti-GBM nephritis in rats by recombinant alpha 3(IV)NC1 and alpha 4(IV)NC1 of type IV collagen. Sado Y; Boutaud A; Kagawa M; Naito I; Ninomiya Y; Hudson BG Kidney Int; 1998 Mar; 53(3):664-71. PubMed ID: 9507212 [TBL] [Abstract][Full Text] [Related]
32. The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif. Hu SY; Gu QH; Wang J; Wang M; Jia XY; Cui Z; Zhao MH J Cell Mol Med; 2017 Sep; 21(9):2117-2128. PubMed ID: 28296059 [TBL] [Abstract][Full Text] [Related]
33. Production and characterization of recombinant Goodpasture antigen in insect cells. Turner N; Forstová J; Rees A; Pusey CD; Mason PJ J Biol Chem; 1994 Jun; 269(25):17141-5. PubMed ID: 8006020 [TBL] [Abstract][Full Text] [Related]
34. Specificity of circulating and tissue-bound autoantibodies in Goodpasture syndrome. Kalluri R; Melendez E; Rumpf KW; Sattler K; Müller GA; Strutz F; Neilson EG Proc Assoc Am Physicians; 1996 Mar; 108(2):134-9. PubMed ID: 8705733 [TBL] [Abstract][Full Text] [Related]
35. Specificity of Goodpasture autoantibodies for the recombinant noncollagenous domains of human type IV collagen. Neilson EG; Kalluri R; Sun MJ; Gunwar S; Danoff T; Mariyama M; Myers JC; Reeders ST; Hudson BG J Biol Chem; 1993 Apr; 268(12):8402-5. PubMed ID: 8473281 [TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of antibodies in Goodpasture syndrome reacting with type IV collagen. Kefalides NA; Ohno N; Wilson CB Kidney Int; 1993 Jan; 43(1):85-93. PubMed ID: 7679459 [TBL] [Abstract][Full Text] [Related]
38. Anti-GBM antibodies in Goodpasture syndrome; anatomy of an epitope. Hellmark T; Segelmark M; Wieslander J Nephrol Dial Transplant; 1997 Apr; 12(4):646-8. PubMed ID: 9140985 [No Abstract] [Full Text] [Related]
39. Antigen and epitope specificity of anti-glomerular basement membrane antibodies in patients with goodpasture disease with or without anti-neutrophil cytoplasmic antibodies. Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY J Am Soc Nephrol; 2007 Apr; 18(4):1338-43. PubMed ID: 17329569 [TBL] [Abstract][Full Text] [Related]